Public Health Genomics Interest Group (PHGIG) Seminar Series

2011-2012 PHGIG Seminar Series

Session 1: Using Tools of Implementation Science to Facilitate Translation
Marc S. Williams, M.D., F.A.A.P., F.A.C.M.G., Director, Intermountain Healthcare Clinical Genetics Institute
Thursday, September 15, 2011
2:00-3:00 P.M.
6130 Executive Blvd, Rockville, MD
Executive Plaza North Conference Rooms C-F

Session 2: The Evolution of Genetic Counseling in the Age of Genomics
Barbara B. Biesecker, Ph.D., Social and Behavioral Research Branch, National Human Genome Research Institute (NHGRI)
Wednesday, November 16, 2011
1:00-2:00 P.M.
6130 Executive Blvd, Rockville, MD
Executive Plaza North, Conference Room H

Session 3: The New NIH Genetic Testing Registry: Peering Into the Black Box of Genetic Tests
Wendy Rubinstein, M.D., Ph.D., F.A.C.M.G., F.A.C.P., Senior Scientist, National Library of Medicine and National Center for Biotechnology Information; Director, NIH Genetic Testing Registry
Wednesday, February 15, 2012
1:00-2:00 P.M.
6130 Executive Blvd, Rockville, MD
Executive Plaza North, Conference Room J

Return to Top

2010 PHGIG Seminar Series: Advances in Public Health Genomics

The 2010 PHGIG seminar series featured examples of discovery to action including case studies across disease categories to illustrate public health genomics interdisciplinary principles as they apply to diseases of public health significance.

View details about the 2010 PHGIG Seminar Series

Click on the talk title or speaker name to view their presentation in PDF format. *

CANCELLED: Session 1: Genomics and human disease: The case of missing heritability
Teri Manolio, M.D., Ph.D. (NHGRI)
Wednesday, February 3, 2010- 1:00-2:00 EPN H

Session 2: Using genomics in risk assessment and prevention of coronary heart disease
Chris O'Donnell, M.D. (NHLBI)
Wednesday, Feb 24, 2010- 1:00-2:00 EPN C-F

Session 3: Three billion base pairs on a chip: so what do we do with our personal genome?
Les Biesecker, M.D. (NHGRI)
Wednesday, March 17, 2010- 1:00-2:00 EPN H

Session 4: Current initiatives in translating human genome discoveries into population health benefits
The genomic applications in practice and prevention network
Muin J. Khoury, MD, Ph.D. (CDC; NCI-DCCPS)
The genetics for early disease detection and intervention initiative
Sharon Terry, M.S. (The Genetic Alliance)
Wednesday, April 14, 2010- 1:00-2:00 6001 Executive Blvd Room C

Session 5: Interferon-alfa, interferon-λ and hepatitis C: Applying genomics to infectious disease
Thomas O'Brien, MD, MPH (NCI)
Wednesday June 2, 2010-1:00-2:00 EPN C-F

Session 6: What are the implications of gene-environment interactions in lung cancer and smoking addiction for prevention and control?

Neil Caporaso, M.D. (NCI): Epidemiologic perspectives
Stephen Marcus, Ph.D. (NCI): Control and prevention perspectives
Kay Wanke, PhD, M.P.H (OBSSR)
Wednesday August 18, 2010-1:00-2:30 EPN C-F

* Note: This user-generated content from the PHGIG seminar series is provided as-is. If you need an accessible version of any of these files, please contact Sheri Schully.

Return to Top

2008-2009 PHGIG Seminar Series: Advances in Public Health Genomics

The emerging scientific translation needs in the genomics era are substantial. Population sciences are now urgently needed to assess the distribution of genetic variants and their products, biomarkers and interactions with other genes and environmental factors. New methods are needed to assess the contribution of genes and gene-environment interactions (behavior, nutrition, chemicals and other exposures) to individual and population risks for various cancers. Behavioral and social sciences are needed to assess how genetic information can be used to affect behavior change to reduce the burden of cancer. Moreover, delivery research on clinical utility, effectiveness and economics of genomics-based health care applications are needed to assess their added value in cancer care and prevention. Genomics and related fields will also affect surveillance, dissemination and diffusion research as well as evaluation of cancer progression and survivorship. Without the expansion of population sciences in genomics, the promise of genome research and discoveries may not reach its full potential.

The 2008-2009 monthly one-hour seminar series entitled, "Advances in Public Health Genomics," specifically explored ongoing, planned and future initiatives led by the NIH and other groups designed to accelerate the process for integrating advances in genomics and related fields into practice. A population approach was emphasized and partnerships between basic sciences, medicine and public health were highlighted.

View details about the 2008-2009 PHGIG Seminar Series

Session 1: Introduction: The genomics translation highway
Muin J. Khoury (CDC, NCI-DCCPS)
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?External Web Site Policy

The NCI TRWG plan for early translational research
Lynn M. Matrisian, Ph.D. (Special Assistant to the Director, NCI)

Wednesday, September 24, 2008 1:00-2:30 EPN C-F

Session 2: Genomics in the GWAS era: What's next for translation?
Teri A. Manolio, M.D., Ph.D.
Director, Office of Population Genomics
Senior Advisor to the Director, NHGRI, for Population Genomics

Genome-wide association studies for complex traits: consensus, uncertainty and challengesExternal Web Site Policy

Genetic mapping in human diseaseExternal Web Site Policy

Genomics in the (Cancer) GWAS era: What's next for translation?
Daniela Seminara, Ph.D., M.P.H.
Epidemiology and Genetics Research Program, DCCPS, NCI

Wednesday, October 22, 2008 1:00-2:30 EPN H

Session 3: Challenges in the analysis of gene-environment interaction in the GWAS era
Exploiting Interactions for Enhanced Detection of Genetic and Environmental Risk-Factors for Complex Diseases

Nilanjan Chatterjee, Ph.D.
Biostatistics Branch, Division of Cancer Epidemiology and Genetics (DCEG), NCI

Studying Interactions between Environmental Exposures and Genetic Variants: Examples and Lessons Learned
Nathaniel Rothman, M.D., M.P.H., M.H.S.
Occupational and Environmental Epidemiology Branch, DCEG, NCI

Wednesday, November 19, 2008 1:00-2:30 EPN H

Session 4: Can multiple genetic variants improve risk assessment and disease prevention?
Sholom Wacholder, Ph.D.
Biostatistics Branch, Division of Cancer Epidemiology and Genetics (DCEG), NCI

How Much Do SNPs Improve Models to Predict Breast Cancer Risk?
Mitchell Gail, M.D., Ph.D.
Biostatistics Branch, Division of Cancer Epidemiology and Genetics (DCEG), NCI

Wednesday, January 28, 2009 1:00-2:30 EPN H

Session 5: Public health approach to pharmacogenomics: From discovery to translation
Rochelle M. Long, Ph.D. (Contact speaker for presentation)
Division of Pharmacology, Physiology, and Biological Chemistry, NIGMS

Pharmacogenomics Translation: From Discovery to Confirmation to Clinical Utility
Andrew N. Freedman, Ph.D.
Division of Cancer Control and Population Sciences, NCI

Wednesday, February 25, 2009 1:00-2:30 EPN H

The March 25, 2009 session will be postponed until June 24, 2009.

Session 6: Personal genome profiles: Transdisciplinary science issues
A Scientific Foundation for Using Personal Genomics for Risk Assessment and Disease Prevention

Muin J. Khoury, M.D., Ph.D.
Director, Office of Public Health Genomics, CDC

Realizing the Health Benefits of Genomics: Which way for translational research?
Colleen McBride, Ph.D.
Chief, Social and Behavioral Research Branch, NHGRI

Wednesday, April 22, 2009 1:00-2:30 EPN G

Session 7: What genomics decision support tools are needed for health practice?
Greg Feero, M.D., Ph.D.
Chief, Genomic Healthcare Branch, NHGRI

Quality Control Checkpoints to Insure High-Quality Genomic Tools for Clinical Practice - A Case Study: OvaSure™, A Proposed Screening Test for Ovarian Cancer
Mark H. Greene, M.D.
Chief, Clinical Genetics Branch, DCEG, NCI

Wednesday, May 27, 2009 1:00-2:30 EPN H

Session 8: Translation and health services research in the genomics era

Clinical Effectiveness and Comparative Effectiveness
Gurvaneet Randhawa, M.D., M.P.H.
Senior Advisor on Clinical Genomics and Personalized Medicine
Center for Outcomes and Evidence, AHRQ

Fostering Translation of Genetic Research on Common Disease: An NIDDK Perspective
Rebekah Rassoly, Ph.D.
Program Director, Genetics & Genomics
Division of Kidney, Urologic & Hematologic Diseases, NIDDK

Wednesday, June 24, 2009 1:00-2:30 EPN C-F

Session 9: Epigenetics in disease control and prevention: When will it be ready for prime time?
Mukesh Verma (NCI-DCCPS)
Wednesday, August 26, 2009 1:00-2:30 EPN H

Return to Top

2007 PHGIG Seminar Series: Public Health Genomics: Closing the Gap Between Gene Discoveries and Population Health

In 2007, the NCI organized a highly successful monthly seminar series entitled, "Public Health Genomics: Closing the Gap Between Gene Discoveries and Population Health." Over nine months, 18 lectures by various expert speakers explored the topic of public health genomics, with a focus on cancer control and prevention.

The 2007 series introduced NIH audiences and beyond to basic concepts of public health genomics. Nevertheless, there is a continued need for raising awareness, developing competencies and generating ideas for initiatives that can integrate genomics into population sciences to assess the role of genomics in practice and prevention. In addition, there are major ongoing genomics initiatives at NCI and other Institutes, as well as cross-cutting NIH Roadmap Initiatives related to genomics. All of these initiatives will lead to new knowledge and gene discoveries that could have lasting impact on healthcare and population health.

Return to Top